NASDAQ:RPHM
Reneo Pharmaceuticals, Inc. Stock News
$1.66
-0.0600 (-3.49%)
At Close: May 31, 2024
Reneo Pharmaceuticals Reports Second Quarter 2021 Financial Results
05:55am, Wednesday, 11'th Aug 2021
First patient dosed in STRIDE study of REN001 in primary mitochondrial myopathies First patient dosed in STRIDE study of REN001 in primary mitochondrial myopathies
Reneo Pharmaceuticals Announces Partial Waiver of Lock-Up Restriction
08:00am, Friday, 09'th Jul 2021
SAN DIEGO, July 09, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patie
Reneo Pharmaceuticals Reports First Quarter 2021 Financial Results
06:00am, Thursday, 20'th May 2021
SAN DIEGO, May 20, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patien
Reneo Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
06:00am, Wednesday, 19'th May 2021
SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patien
US IPO Weekly Recap: The IPO Market Cools Off In A 2 IPO Week
02:17pm, Sunday, 11'th Apr 2021
Just two IPOs priced this past week, raising $222 million as the US IPO market continued to cool down. The IPO pipeline remained active, with 13 IPOs and 14 SPACs submitting initial filings this week.
Two Biotechs Are Set to Start Trading Today
11:34am, Friday, 09'th Apr 2021
VectivBio Holding and Reneo Pharmaceuticals are making their market debuts on Nasdaq.
Reneo Pharmaceuticals Announces Pricing of Initial Public Offering
09:42pm, Thursday, 08'th Apr 2021
SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare,
